CRIXIVAN vs REYATAZ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. CRIXIVAN and REYATAZ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CRIXIVAN	REYATAZ
Rating	70/100	72/100
Pharmacy pays	—	~$51.44 /30
Type	RX	RX
Active ingredient	INDINAVIR SULFATE	ATAZANAVIR SULFATE
Manufacturer	Merck Sharp Dohme	Bristol Myers Squibb
Dosage forms	Capsule	Capsule, Powder
Drug class	—	Protease Inhibitor
Boxed warning	None	None
Treats	Acquired Immunodeficiency Syndrome	Acquired Immunodeficiency Syndrome

crixivan reyataz

Rating

70/100

72/100

Pharmacy pays

—

~$51.44 /30

Type

Active ingredient

INDINAVIR SULFATE

ATAZANAVIR SULFATE

Manufacturer

Merck Sharp Dohme

Bristol Myers Squibb

Dosage forms

Capsule

Capsule, Powder

Drug class

—

Protease Inhibitor

Boxed warning

None

Treats

Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Crixivan or Reyataz?

By our independent rating, Reyataz scores higher — 3.6 vs 3.5 out of 5 for Crixivan. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Crixivan and Reyataz?

Crixivan contains Indinavir Sulfate, while Reyataz contains Atazanavir Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.